Trump signs most-favored-nation drug-pricing deals with nine more pharma companies
President Trump announced a new round of most-favored-nation drug-pricing agreements, adding nine companies including Astellas, Teva, and Sun to the program. The announcement was made on September 1, 2026, as part of the administration's ongoing drug-pricing push.
Detected & updated continuously · Source: Nebula
Story subjects
Sources
@qz
Trump signs drug-pricing deals with nine more pharma companies under most-favored-nation push: President Trump announced a new round of most-favored-nation drug-pricing agreements Monday, adding nine companies — including Astellas, Teva, Sun… https://t.co/bPe6rt5qcf https://t.co/6QD0wlDGoY
@dcexaminer
OP-ED: Trump promised to ‘drain the swamp.’ His FDA pick just refilled it | Ericka Andersen https://t.co/sFBMqcJ2HW